Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Microneedle arrays with nanotechnology show promise for painless drug delivery through the skin but need more research on safety and effectiveness.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Patient had scalp allergy from minoxidil; test helped identify cause and suggest alternative treatments.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

Hair loss in teenagers is hard to treat and lacks a cure, with some treatments available depending on the type of hair loss.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.

Treating hirsutism in women often requires a mix of medications and cosmetic methods for best results.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Hirsutism, excessive hair growth in women, is often caused by PCOS and can be managed with medication and personalized treatment plans.

The document concludes that hair loss is complex, affects many people, has limited treatments, and requires more research on its causes and psychological impact.

Some cosmetic procedures show promise for treating hair loss, but more research is needed to confirm their safety and effectiveness.

The document concludes that alopecia areata is an unpredictable autoimmune hair loss condition with no cure, but various treatments exist that require personalized approaches.

The document reviews various hair and nail disorders, their causes, and treatments, emphasizing the need for proper diagnosis and the link between nail changes and systemic diseases.

Animal research has greatly advanced dermatology.

Various local treatments for alopecia areata show promise, but individualized plans and more research are needed.

Adding PRP to topical mometasone improves and speeds up alopecia areata treatment.

The document concludes that identifying the cause of eyebrow and eyelash loss is key to treating it and improving quality of life.

Diphenylcyclopropenone is more effective and has fewer side effects than dinitrochlorobenzene for treating alopecia areata.

No cure exists for alopecia areata, and treatments are personalized.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

Up to half of women by age 50 experience significant hair loss, with various types and treatments available.

Alopecia areata is a reversible, autoimmune-related hair loss that can have significant emotional impact and uncertain treatment effectiveness.